Clinical trials
Screening clinical trials
Below are recruiting screening clinical trials, each written for real people, not researchers. We’re tracking 922 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04258293Recruiting
Diabetes screening for people taking steroid tablets long term
This trial checks whether people who take steroid medicines for more than 3 months are developing early diabetes, using blood tests before and around starting treatment. It may help catch diabetes sooner if it’s starting to develop, even in people who didn’t have diabetes yet.
DijonAges 18 years+ - NCT04328532Recruiting
MRI check for abnormal placenta attachment risk
This study uses an MRI scan during late pregnancy to look for signs that the placenta may be abnormally attached. The goal is to help doctors plan safer care before birth, especially for people with higher-risk pregnancy features.
Vandœuvre-lès-NancyAges 18 years+ - NCT04254133Enrolling by invitation
Study uses genetics to guide prostate cancer care and screening
This study collects saliva and health/family history information to learn how inherited (genetic) factors relate to prostate cancer. The goal is to improve how treatment and future screening are planned for people and families.
Seattle, WashingtonAges 35–89 - NCT04226313Recruiting
Home self-swab tests for people not doing cervical screening
This study looks at whether a home self-sampling swab can help people who haven’t joined cervical cancer screening in the past few years. If you qualify, you’ll be asked to collect a swab yourself so it can be tested, aiming to make screening easier to access.
OlomoucAges 30–65 - NCT04085900Recruiting
Screening test for nasopharyngeal cancer blood markers
This study screens people in certain cities to see whether signs in the blood related to a virus (EBV) can help find nasopharyngeal cancer earlier. It may help identify higher-risk people so they can be checked sooner.
Zhongshan, GuangdongAges 30–69 - NCT04093388Recruiting
At-home Pap test to improve cervical screening in rural areas
This study looks at using a self-collected Pap test (a sample you collect yourself) to help people get routine cervical cancer screening. It may help improve screening rates, especially for those in rural areas where getting to a clinic can be harder.
Birmingham, AlabamaAges 21–65 - NCT04045470Recruiting
Skin-device test to find drugs for T-cell lymphoma lesions
This trial tests a tiny device placed directly into skin lymphoma spots to help identify which “candidate” drugs could work. It’s mainly aimed at people with measurable skin involvement from T-cell lymphoma, after they stop certain treatments for a set time.
Boston, MassachusettsAges 18 years+ - NCT04107181Recruiting
Speculum-free screening for cervical cancer testing
This pilot study tests a new way to check for cervical cancer that does not use a speculum (a tool used during pelvic exams). If you qualify, you may be offered this alternative screening method as part of the study.
Durham, North CarolinaAges 21–65 - NCT04075162Recruiting
Free heart calcium scan program at University Hospitals
This study is looking at people who already received a free coronary artery calcium (CAC) CT scan through a community screening program at University Hospitals. It may help the hospital understand who benefits from offering these no-cost scans.
Cleveland, OhioAges 18–100 - NCT03915418Recruiting
Screening sleep problems in children with cerebral palsy
This trial checks a new way to find sleep problems in children with cerebral palsy using connected tools (like devices/apps). It mainly helps by making sleep screening easier and more accurate, so families can get the right next steps sooner.
AngersAges 6–15 - NCT03937453Recruiting
Pancreatic cancer screening for people with new or worsening diabetes
This study checks whether regular imaging can find pancreatic cancer earlier in people who recently developed diabetes or whose diabetes is getting worse. It may help detect pancreatic problems sooner when treatment options are likely better.
New Haven, ConnecticutAges 50 years+ - NCT03877796Recruiting
Pre-screening study for ovarian cancer after platinum treatment
This trial is a pre-screening process for people with ovarian cancer whose disease came back quickly after platinum chemotherapy (or who cannot take platinum). It may help match you to future study options using a tumor tissue sample.
Tampa, FloridaAges 18 years+ - NCT03563976Recruiting
Imaging study for lung cancer outcomes
This study looks at medical images from people with lung cancer to see how image findings relate to outcomes. It may help doctors better understand which imaging features predict results for patients.
Dallas, TexasAges 18–99 - NCT03689595Enrolling by invitation
PROMISE study: Predicting myeloma risk in high-risk groups
This study uses a blood test to find early signs of myeloma in people at higher risk, such as those with a family history or African ancestry. It aims to predict who might develop myeloma before symptoms appear.
Boston, MassachusettsAges 30 years+ - NCT03713229Enrolling by invitation
Seville study of people with HIV at risk for anal cancer
This study follows people living with HIV who may be at higher risk for anal cancer. It aims to better understand risk and outcomes, which could help guide future screening or prevention.
SevilleAges 18 years+ - NCT03478852Recruiting
Epilepsy screening and evaluation for people 8 and older
This study checks how people with known or suspected epilepsy are evaluated and followed. It may help by improving screening and understanding care for epilepsy in children and adults.
Bethesda, MarylandAges 8–110 - NCT03423303Enrolling by invitation
Screening test to find early prostate cancer sooner
This trial checks whether an early prostate cancer screening approach can detect clinically significant prostate cancer sooner. It may help participants catch the disease at an earlier stage when treatment can be more effective.
HelsinkiAges 50–63 - NCT03250078Recruiting
Pancreatic cancer screening for people at high genetic risk
This study offers pancreatic cancer screening for people with strong family history or certain inherited gene changes. It may help find pancreatic cancer earlier, when treatment may be more effective.
Norwalk, ConnecticutAges 50–90 - NCT03124212Recruiting
Genetic testing guidance for inherited breast, ovarian, or colon cancer risk
This study helps people in Switzerland who already have a known inherited cancer gene change understand what it means for them and their family. It focuses on people with specific known mutations related to hereditary breast/ovarian cancer and Lynch syndrome.
Fribourg, Canton of FribourgAges 18 years+ - NCT02834884Recruiting
Helps match cancer patients to clinical trials using screening
This study screens certain cancer types and collects a sample to check it’s good enough for future trial matching and research. If you qualify, your care team may use your sample to help find the most efficient clinical trial options.
ViennaAges 12 years+ - NCT02977780RecruitingPhase 2
Targeted treatment plan for specific glioblastoma tumor markers
This Phase 2 trial tests an individualized treatment approach for glioblastoma or gliosarcoma based on your tumor’s lab tests. It may help by matching therapy to tumor features and by checking how well this strategy works after surgery and planned radiation.
Birmingham, AlabamaAges 18 years+ - NCT02688894Recruiting
Molecular testing for relapsed small cell lung cancer
This study uses tumor tissue to look for molecular (biologic) changes after your small cell lung cancer comes back. It may help doctors choose the most appropriate next treatment based on what the cancer’s biology shows.
IncheonAges 20 years+ - NCT02897908Recruiting
Noninvasive scan to check liver fat and scarring
This study tests a noninvasive FibroScan machine to help measure liver fat and possible liver scarring using information collected in a database. It may help researchers improve how liver problems like fat buildup and scarring are identified and tracked.
Buffalo, New YorkAges 18 years+ - NCT02639299Recruiting
Screening healthy adults for malaria vaccines and drug studies
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
Bethesda, MarylandAges 18–50
Hear when a new Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for screening?
- Yes. Clin2 currently lists 922 recruiting screening studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a screening trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a screening trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.